CollPlant Biotechnologies annual capital expenditures (capex)
2017
2018
2019
2020
2021
2022
2023
2024
2025
CollPlant Biotechnologies Capital Expenditures (CapEx) Growth & History (CLGN)
CollPlant Biotechnologies's capital expenditures (capex) was $28,000 for fiscal 2025.
View full CollPlant Biotechnologies company overviewCollPlant Biotechnologies annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $28,000 | −$455,000 | −94.20% |
| 2024 | 2024-12-31 | $483,000 | −$471,000 | −49.37% |
| 2023 | 2023-12-31 | $954,000 | −$320,000 | −25.12% |
| 2022 | 2022-12-31 | $1.3M | −$154,000 | −10.78% |
| 2021 | 2021-12-31 | $1.4M | $991,000 | +226.77% |
| 2020 | 2020-12-31 | $437,000 | −$1.1M | −70.69% |
| 2019 | 2019-12-31 | $1.5M | $659,000 | +79.21% |
| 2018 | 2018-12-31 | $832,000 | $705,000 | +555.12% |
| 2017 | 2017-12-31 | $127,000 | — | — |
CollPlant Biotechnologies quarterly capital expenditures (capex)
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $6,000 | −$3,000 | −33.33% |
| Q4 2025 | 2025-12-31 | $15,000 | — | — |
| Q3 2025 | 2025-09-30 | $1,000 | — | — |
| Q2 2025 | 2025-06-30 | $3,000 | — | — |
| Q1 2025 | 2025-03-31 | $9,000 | — | — |
CollPlant Biotechnologies capital expenditures (capex) trends
Over the last five fiscal years, CollPlant Biotechnologies's capital expenditures (capex) decreased from $437,000 to $28,000, a change of −$409,000. The latest reported quarter, Q1 2026, shows $6,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CollPlant Biotechnologies source filings ↗